Abstract
Experts in the field of obstetrics and gynecology recently met to discuss issues related to the epidemiology, diagnosis, and treatment of premenstrual syndrome/premenstrual dysphoric disorder (PMS/PMDD) in Latin American countries. The experts reviewed the existing accepted guidelines related to these issues and discussed adaptations to the diagnostic criteria and treatment recommendations in order to meet the specific needs of women in Latin American countries. This manuscript provides an overview of key information presented at this meeting and provides an up-to-date assessment of emerging treatment options covered in existing guidelines and treatment reviews. In addition, we discuss the relevance and possible application of this expanded knowledge to Latin American countries and provide practical recommendations for the diagnosis and management of PMS/PMDD in this setting.
Original language | English (US) |
---|---|
Pages (from-to) | 263-277 |
Number of pages | 15 |
Journal | Disease Management and Health Outcomes |
Volume | 15 |
Issue number | 5 |
DOIs | |
State | Published - 2007 |
Keywords
- Anxiolytics, therapeutic use
- Danazol, therapeutic use
- Gonadotropin releasing hormone agonists, therapeutic use
- Oral contraceptives, therapeutic use
- Premenstrual dysphoric disorder, assessment
- Serotonin reuptake inhibitors, therapeutic use
ASJC Scopus subject areas
- General Nursing
- Leadership and Management
- Health Policy